ID   NCC-DMM1-C1
AC   CVCL_B5PV
DR   GEO; GSM5606630
DR   GEO; GSM5606631
DR   GEO; GSM5618185
DR   Wikidata; Q112129413
RX   PubMed=35069873;
CC   Population: Japanese.
CC   Doubling time: 25.9 hours (PubMed=35069873).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=35069873
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 29,32.2
ST   D5S818: 9,11
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C45664; Pleural desmoplastic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
RX   PubMed=35069873; DOI=10.3892/ol.2021.13182; PMCID=PMC8756558;
RA   Noguchi R., Yoshimatsu Y., Ono T., Sei A., Motoi N., Yatabe Y.,
RA   Yoshida Y., Watanabe S., Kondo T.;
RT   "Establishment and characterization of NCC-DMM1-C1, a novel
RT   patient-derived cell line of desmoplastic malignant pleural
RT   mesothelioma.";
RL   Oncol. Lett. 23:64.1-64.9(2022).
//